Thermo Fisher Scientific | TMO - Umlaufvermögen

Aktienkurs
471.91
Täglich Wechseln
2.20 0.47%
Monatlich
-3.84%
Jährlich
11.24%
Q2 Prognose
459.66




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
Agilent USD 4.62B 21M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
Edwards Lifesciences USD 6.74B 380M 2025-12
General Electric Aerospace USD 40.36B 235M 2026-03
Henry Schein USD 4.46B 69M 2025-12
Illumina USD 3.29B 493M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Medtronic USD 24.07B 75M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
Olympus JPY 652.65B 47.58B 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Veracyte USD 488.38M 39.15M 2025-12
Waters USD 1.99B 69.86M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12